Asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Asthma involves chronic inflammation of the airways, leading to increased sensitivity to various triggers. This inflammation causes swelling and narrowing of the airways, making breathing difficult and leading to the characteristic wheezing and shortness of breath.

• Secondary mechanism: In response to triggers, the smooth muscles surrounding the airways constrict, a process known as bronchoconstriction. This further narrows the airways, exacerbating symptoms and contributing to airflow obstruction.

• Key complication: Persistent inflammation and bronchoconstriction can lead to airway remodeling, where structural changes in the airway walls occur. This can result in a progressive decline in lung function and increased frequency and severity of asthma attacks.

Patient Profile

Demographics:

27-year-old female, office manager

History:

• Key past medical history: Diagnosed with asthma at age 15, seasonal allergies, occasional gastroesophageal reflux disease (GERD)

• Current medications: Albuterol inhaler as needed, Fluticasone inhaler daily, Montelukast 10 mg daily

• Allergies: Penicillin, pollen

Current Presentation:

• Chief complaint: Increased shortness of breath and wheezing over the past two weeks

• Key symptoms: Persistent cough, chest tightness, difficulty sleeping due to breathing issues, mild fever, fatigue

• Vital signs: Temperature 100.4°F (38°C), Heart rate 102 bpm, Respiratory rate 22 breaths per minute, Blood pressure 130/85 mmHg, Oxygen saturation 92% on room air

Section 1

As the patient's condition continues to be evaluated, the initial assessment findings reveal significant concerns that warrant further investigation. On auscultation, there is a notable decrease in breath sounds in the lower lobes, accompanied by diffuse expiratory wheezes, indicating bronchoconstriction and airflow limitation. The patient's work of breathing is visibly increased, characterized by the use of accessory muscles and nasal flaring. Upon further examination, there are signs of respiratory distress, with the patient appearing anxious and having difficulty completing full sentences due to dyspnea.

Laboratory tests are conducted to obtain a clearer picture of the patient's status. Arterial blood gas analysis shows respiratory acidosis with a pH of 7.32, partial pressure of carbon dioxide (PaCO2) at 58 mmHg, and partial pressure of oxygen (PaO2) at 65 mmHg, indicating hypoventilation and impaired gas exchange. These findings suggest the development of a moderate asthma exacerbation, requiring a reassessment of the current management plan. A chest X-ray is ordered to rule out any potential complications such as pneumonia or pneumothorax, which could contribute to the patient's symptoms and decreased oxygen saturation.

These assessment findings and diagnostic results highlight the need for prompt intervention to prevent further deterioration. The patient's current medication regimen may require adjustment, including the potential introduction of systemic corticosteroids to address the underlying inflammation and prevent airway remodeling. Close monitoring of the patient's response to treatment and frequent reassessment of vital signs, oxygen saturation, and symptom progression will be crucial in guiding the next steps of care. This scenario presents an opportunity for clinical reasoning to optimize asthma management and prevent further complications.

Section 2

Response to Interventions

Following the initial assessment and diagnostic findings, the healthcare team swiftly implements a revised management plan to address the patient's moderate asthma exacerbation. The patient is started on high-flow supplemental oxygen to improve oxygenation, targeting an oxygen saturation level above 92%. In addition, systemic corticosteroids are administered intravenously to reduce airway inflammation, while nebulized bronchodilators are given to alleviate bronchoconstriction. These interventions aim to stabilize the patient's respiratory status and improve gas exchange.

Over the next several hours, careful monitoring is essential to evaluate the patient's response to treatment. The nursing team observes a gradual improvement in the patient's work of breathing. Accessory muscle use decreases, and the patient can complete short sentences with less effort, indicating a reduction in dyspnea. Vital signs show a heart rate of 98 bpm, respiratory rate of 24 breaths per minute, and blood pressure of 128/82 mmHg. However, repeat arterial blood gas analysis reveals persistent respiratory acidosis with a pH of 7.34, PaCO2 of 55 mmHg, and PaO2 of 70 mmHg, suggesting only a partial response to the interventions.

Despite the initial improvement, the patient begins to exhibit new symptoms of increased fatigue and lethargy, raising concerns about potential respiratory muscle fatigue and impending respiratory failure. The healthcare team deliberates the need for further escalation of care, considering options such as non-invasive positive pressure ventilation to provide respiratory support and prevent further deterioration. The case highlights the importance of ongoing assessment and clinical reasoning to adjust the treatment plan and ensure optimal outcomes for the patient.

Section 3

New Complications

As the hours progress, the patient begins to show signs of worsening respiratory status despite the interventions. The nursing team notes an increase in the patient's respiratory rate to 30 breaths per minute and a heart rate climbing to 110 bpm. The patient is now unable to maintain an oxygen saturation above 90% even with high-flow supplemental oxygen. Auscultation of the lungs reveals diminished breath sounds with scattered wheezes, and the patient is visibly struggling to breathe, with marked use of accessory muscles returning.

In response to these troubling developments, the healthcare team orders a repeat arterial blood gas analysis, which reveals further deterioration: the pH has dropped to 7.28, indicating worsening acidosis, while the PaCO2 has risen to 60 mmHg, and PaO2 has decreased to 65 mmHg. These results confirm the team's suspicion of escalating respiratory failure. Additionally, a chest X-ray is conducted to rule out any complications such as pneumothorax or pneumonia, and it shows no acute findings other than hyperinflation consistent with asthma.

Given the new data and clinical findings, the team deliberates the necessity of escalating care to prevent respiratory arrest. They consider the initiation of non-invasive positive pressure ventilation to assist with breathing and reduce the workload on the respiratory muscles. The plan also includes close monitoring in an intensive care setting, where the patient can receive more intensive observation and rapid intervention if needed. The unfolding situation underscores the critical need for timely clinical reasoning and decision-making to adjust the management plan dynamically as the patient's condition evolves.

Section 4

As the patient is transitioned to the intensive care unit, the clinical team implements non-invasive positive pressure ventilation (NIPPV) to improve ventilation and reduce the work of breathing. Initially, the patient shows slight improvement; respiratory rate decreases to 26 breaths per minute, and oxygen saturation rises to 92%. However, within a few hours, the patient's condition begins to change. The patient becomes increasingly agitated and is unable to tolerate the mask, leading to further desaturation.

Repeat arterial blood gas analysis reveals further decline: the pH has decreased to 7.25, PaCO2 has risen to 65 mmHg, and PaO2 has further decreased to 60 mmHg. These findings indicate ongoing respiratory acidosis and hypoxemia despite the current interventions. Additionally, the patient’s heart rate has increased to 120 bpm, and blood pressure has become labile, ranging between 140/90 mmHg and 100/60 mmHg, indicating possible cardiovascular stress in response to respiratory compromise and agitation.

The healthcare team recognizes that the patient is now facing a critical juncture, with the potential for respiratory arrest if the underlying issues are not swiftly addressed. The deteriorating blood gas values and cardiovascular instability prompt the team to consider endotracheal intubation and mechanical ventilation to stabilize the patient and ensure adequate oxygenation and ventilation. The decision to escalate care is weighed carefully, considering the risk of barotrauma and infection associated with mechanical ventilation, but deemed necessary to prevent further deterioration. This critical decision underscores the importance of continuous assessment and dynamic adjustment of the management plan in response to evolving clinical conditions.

Section 5

As the decision to proceed with endotracheal intubation and mechanical ventilation is made, the healthcare team prepares to implement the intervention with precision and urgency. The patient is sedated and intubated successfully, with the endotracheal tube secured in place. Mechanical ventilation is initiated with settings adjusted to ensure adequate oxygenation and ventilation while minimizing the risk of barotrauma. The ventilator is set to a tidal volume of 6 mL/kg, a respiratory rate of 14 breaths per minute, and a positive end-expiratory pressure (PEEP) of 5 cm H2O to optimize alveolar recruitment.

Following intubation, the patient's initial response to mechanical ventilation is cautiously optimistic. Arterial blood gas analysis conducted shortly after intubation shows a slight improvement in the patient's acid-base balance: pH has risen to 7.30, PaCO2 has decreased to 55 mmHg, and PaO2 has increased to 75 mmHg, indicating partial correction of respiratory acidosis and hypoxemia. However, the patient's heart rate remains elevated at 115 bpm, and the blood pressure continues to fluctuate, suggesting ongoing cardiovascular stress. The team recognizes that while the immediate threat of respiratory arrest has been mitigated, the patient's condition remains fragile, and continuous monitoring is essential.

Despite the initial improvements, the patient's condition takes a new turn when crackles are auscultated bilaterally, and the patient develops a fever of 38.5°C. A chest X-ray is ordered, revealing diffuse bilateral infiltrates, raising concerns about the development of ventilator-associated pneumonia (VAP). The healthcare team promptly initiates a broad-spectrum antibiotic regimen while awaiting culture results to tailor therapy appropriately. This development highlights the complex interplay of respiratory and infectious complications in critically ill patients and emphasizes the need for vigilant assessment and timely intervention to address emerging challenges in the patient's care trajectory.